Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82902502 | 8290250 | 2 | F | 20110810 | 20111228 | 20111122 | 20120426 | PER | PHEH2011US02896 | NOVARTIS | 57.00 | YR | F | N | 0.00000 | 20120306 | OT | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82902502 | 8290250 | 1 | PS | GILENYA | 1 | ORAL | 0.5 MG, DAILY, ORAL | N | 22527 | ||||||||||
| 82902502 | 8290250 | 3 | C | COPAXONE (GLATIRAMER ACETATE) | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 82902502 | 8290250 | 1 | MULTIPLE SCLEROSIS |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 82902502 | 8290250 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 82902502 | 8290250 | Herpes zoster | |
| 82902502 | 8290250 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 82902502 | 8290250 | HP |
Therapies reported
| no results found |